
Home » PRDT ANNOUNCES SIGNING OF LICENSE AGREEMENT
PRDT ANNOUNCES SIGNING OF LICENSE AGREEMENT
Pathogen Removal and Diagnostic Technologies Inc. (PRDT), a joint venture between ProMetic Life Sciences Inc. (TSX:PLI) and the American Red Cross, today announced that it has signed a definitive license agreement with MacoPharma.
CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=595662)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct